D-Leu7-Triptorelin substitutes a D-leucine at position seven, modifying local chirality and hydrophobic packing. Researchers examine its altered receptor-binding patterns and enhanced stability. Applications include analog design, stereochemical studies, and structure-function analysis.
CAT No: Z10-101-181
Synonyms/Alias:(S)-N-(2-Amino-2-oxoethyl)-1-(((S)-5-oxopyrrolidine-2-carbonyl)-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-tryptophyl-D-leucyl-L-arginyl)pyrrolidine-2-carboxamide
D-Leu7-Triptorelin is a synthetic peptide analog derived from the naturally occurring gonadotropin-releasing hormone (GnRH) decapeptide. Structurally characterized by the substitution of D-leucine at the seventh position, this modified peptide exhibits altered receptor binding properties and metabolic stability compared to native GnRH or standard triptorelin. Its unique sequence modification provides a valuable tool for probing the structure-activity relationships of GnRH analogs, making it highly relevant for research in endocrinology, receptor pharmacology, and peptide engineering. The compound is widely recognized for its utility in elucidating the mechanisms of peptide-receptor interactions and for supporting the development of novel peptide-based probes in the field of hormone signaling.
Peptide receptor binding studies: D-Leu7-Triptorelin serves as a critical reagent for investigating the molecular determinants of GnRH receptor affinity and specificity. By introducing a D-amino acid at a key position, researchers can assess how stereochemical modifications influence ligand-receptor interactions, receptor activation, and downstream signaling pathways. This enables the detailed mapping of binding domains and provides insights into the conformational requirements for optimal receptor engagement, which is essential for the rational design of next-generation GnRH analogs.
Peptide stability and degradation research: The incorporation of D-leucine into the peptide backbone confers increased resistance to enzymatic degradation by endogenous peptidases. This property makes the analog a valuable model for studying peptide stability in various biological matrices, such as serum or tissue homogenates. Researchers utilize D-Leu7-Triptorelin to compare degradation rates, identify proteolytic cleavage sites, and evaluate strategies for enhancing the metabolic stability of peptide therapeutics or probes.
Structure-activity relationship (SAR) analysis: D-Leu7-Triptorelin is frequently employed in SAR studies aimed at dissecting the functional contributions of individual amino acid residues within the GnRH sequence. By systematically substituting native residues with D-amino acids or other analogs, scientists can pinpoint structural motifs critical for biological activity, receptor selectivity, and agonist/antagonist profiles. These findings inform the development of custom-engineered peptides with tailored pharmacological properties for research applications.
Peptide synthesis method validation: The synthesis of D-Leu7-Triptorelin provides an effective test case for validating solid-phase peptide synthesis (SPPS) protocols and optimizing coupling strategies, particularly when incorporating D-amino acids. Analytical evaluation of the final product, including chromatographic and spectrometric characterization, enables quality control and method refinement. As such, the analog is used as a benchmark in synthetic laboratories to ensure the reliability and reproducibility of peptide manufacturing processes.
Hormone signaling pathway elucidation: As a GnRH analog with altered receptor activity, D-Leu7-Triptorelin is utilized to dissect the intricacies of hormone-mediated signaling cascades. Researchers introduce the analog into in vitro and ex vivo systems to monitor changes in receptor activation, second messenger generation, and gene expression profiles. These experiments help clarify the functional consequences of structural modifications within peptide hormones and contribute to a deeper understanding of endocrine regulation at the molecular level.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More